These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22508529)

  • 41. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.
    Lin C; Jiang X; Dai Z; Guo X; Weng T; Wang J; Li Y; Feng G; Gao X; He L
    J Bone Miner Res; 2009 Oct; 24(10):1651-61. PubMed ID: 19419300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of bone morphogenetic proteins in traumatology.
    Westerhuis RJ; van Bezooijen RL; Kloen P
    Injury; 2005 Dec; 36(12):1405-12. PubMed ID: 16125704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variations of SOST mRNA expression in human bone are associated with DNA polymorphism and DNA methylation in the SOST gene.
    Lhaneche L; Hald JD; Domingues A; Hannouche D; Delepine M; Zelenika D; Boland A; Ostertag A; Cohen-Solal M; Langdahl BL; Harsløf T; de Vernejoul MC; Geoffroy V; Jehan F
    Bone; 2016 Nov; 92():107-115. PubMed ID: 27519970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone morphogenetic proteins and their antagonists: the sclerostin paradigm.
    van Bezooijen RL; Papapoulos SE; Löwik CW
    J Endocrinol Invest; 2005; 28(8 Suppl):15-7. PubMed ID: 16323824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic predisposition to non-union: evidence today.
    Dimitriou R; Kanakaris N; Soucacos PN; Giannoudis PV
    Injury; 2013 Jan; 44 Suppl 1():S50-3. PubMed ID: 23351872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression.
    Haynes KR; Tseng HW; Kneissel M; Glant TT; Brown MA; Thomas GP
    BMC Musculoskelet Disord; 2015 Nov; 16():368. PubMed ID: 26612313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Sclerostin super-producer cell line derived from the human cell line SaOS-2: a new tool for the study of the molecular mechanisms driving Sclerostin expression.
    Pérez-Campo FM; Sañudo C; Delgado-Calle J; Arozamena J; Zarrabeitia MT; Riancho JA
    Calcif Tissue Int; 2014 Aug; 95(2):194-9. PubMed ID: 24913258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcriptional control of Sost in bone.
    Sebastian A; Loots GG
    Bone; 2017 Mar; 96():76-84. PubMed ID: 27771382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is the expression of Transforming Growth Factor-Beta1 after fracture of long bones solely influenced by the healing process?
    Kaiser G; Thomas A; Köttstorfer J; Kecht M; Sarahrudi K
    Int Orthop; 2012 Oct; 36(10):2173-9. PubMed ID: 22623064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of Sclerostin in Osteoporotic Fracture Patients Is Associated with DNA Methylation in the CpG Island of the
    Cao Y; Wang B; Wang D; Zhan D; Mai C; Wang P; Wei Q; Liu Y; Wang H; He W; Xu L
    Int J Genomics; 2019; 2019():7076513. PubMed ID: 30729116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does mammalian target of rapamycin or sestrin 1 protein signaling have a role in bone fracture healing?
    Pazarci Ö; Doğan HO; Kilinç S; Çamurcu IY
    Turk J Med Sci; 2019 Dec; 49(6):1774-1778. PubMed ID: 31655537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis.
    Lucijanic M; Livun A; Tupek KM; Stoos-Veic T; Pejsa V; Kusec R
    Ann Hematol; 2018 Jul; 97(7):1293-1294. PubMed ID: 29532161
    [No Abstract]   [Full Text] [Related]  

  • 53. Increase in sclerostin levels is associated with fracture healing in humans.
    Bonekey Rep; 2012; 1():137. PubMed ID: 23951517
    [No Abstract]   [Full Text] [Related]  

  • 54. Impact of a local 5-lipoxygenase inhibitor on bone formation during fracture healing.
    Bonekey Rep; 2013; 2():418. PubMed ID: 24422121
    [No Abstract]   [Full Text] [Related]  

  • 55. Sost, ECR5, Mef2C and van Buchem disease.
    Bonekey Rep; 2012; 1():204. PubMed ID: 24049632
    [No Abstract]   [Full Text] [Related]  

  • 56. Changing levels of four key growth factors after a long bone fracture.
    Bonekey Rep; 2013; 2():319. PubMed ID: 24422067
    [No Abstract]   [Full Text] [Related]  

  • 57. The role of Wnt signaling on Tooth Extraction Wound Healing: Narrative review.
    Khoswanto C; Dewi IK
    Saudi Dent J; 2024 Apr; 36(4):516-520. PubMed ID: 38690381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Close negative correlation of local and circulating Dickkopf-1 and Sclerostin levels during human fracture healing.
    Starlinger J; Santol J; Kaiser G; Sarahrudi K
    Sci Rep; 2024 Mar; 14(1):6524. PubMed ID: 38499638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Muscle-bone crosstalk via endocrine signals and potential targets for osteosarcopenia-related fracture.
    Sheng R; Cao M; Song M; Wang M; Zhang Y; Shi L; Xie T; Li Y; Wang J; Rui Y
    J Orthop Translat; 2023 Nov; 43():36-46. PubMed ID: 38021216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of Osteopenia During Distal Radius Fracture Recovery.
    Yousaf IS; Guarino GM; Sanghavi KK; Rozental TD; Means KR; Giladi AM
    J Hand Surg Glob Online; 2022 Nov; 4(6):315-319. PubMed ID: 36425381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.